Which of the following is correct about Polycystic Ovary Syndrome (PCOS) in relation to menstrual symptoms?

NORCET 8 Prelims-2025

Obstetrics & Gynecology

Medium

Appeared in: NORCET 8 Prelims-2025

Explanation

Polycystic Ovary Syndrome (PCOS) is fundamentally characterized by oligo-ovulation or anovulation, meaning ovulation is infrequent or absent.
The luteal phase of the menstrual cycle is dependent on the formation of the corpus luteum, which only occurs after ovulation.
In anovulatory cycles common in PCOS, no corpus luteum forms, leading to a failure of the luteal phase and insufficient progesterone production.
This condition is known as a luteal phase defect, which directly results in the irregular menses seen in PCOS.

Option B: Symptoms like bloating and constipation are more classically associated with Premenstrual Syndrome (PMS), which occurs during the luteal phase of a normal ovulatory cycle. They are not defining characteristics of PCOS.
Option C: This statement describes a treatment, not a symptom or a pathophysiological feature of PCOS. Also, lifestyle modification is often considered the true first-line intervention, especially in overweight individuals.
Option D: This is the direct opposite of what occurs in PCOS. The condition's core menstrual dysfunction is anovulation (lack of ovulation) or oligo-ovulation (infrequent ovulation).

Visual 1: Diagram - A flowchart comparing the hormonal cascade of a normal ovulatory menstrual cycle versus an anovulatory cycle in PCOS, highlighting the absence of the LH surge and subsequent lack of progesterone.
Visual 2: Image - A side-by-side comparison of a transvaginal ultrasound showing a normal ovary versus a polycystic ovary, with labels pointing to the multiple small antral follicles ('string of pearls' appearance).

Clinical Relevance

Nursing practice connection: Use the key finding related to Pathophysiology of menstrual dysfunction in Polycystic Ovary Syndrome (PCOS) to guide bedside assessment, documentation, and the next nursing action.
The chronic anovulation in PCOS leads to unopposed estrogen stimulation of the endometrium, which significantly increases the patient's risk for endometrial hyperplasia and endometrial cancer. Cycle regulation with progestins or OCPs is a key nursing intervention for risk reduction.
Nurses play a vital role in educating patients about PCOS, emphasizing that it is a metabolic and endocrine syndrome, not just a reproductive issue. Counseling should include risks for type 2 diabetes, dyslipidemia, and cardiovascular disease.
What if? If the patient with PCOS expressed a desire for pregnancy, the management approach would change completely. Instead of using OCPs to suppress ovulation, the first-line treatment would shift to ovulation induction agents like letrozole or clomiphene citrate to stimulate follicle growth and release.

How to Approach the Question

First, identify the core concept of the question: the relationship between PCOS and menstrual symptoms.
Recall the defining pathophysiological feature of PCOS, which is chronic anovulation or oligo-ovulation.
Analyze each option based on this core feature.
Option A (Luteal phase defect): A lack of ovulation means no corpus luteum, which defines a defective luteal phase. This is a direct consequence.
Option B (Bloating, etc.): Recognize these as PMS symptoms, which require an ovulatory cycle.
Option C (OCPs): Identify this as a treatment, not a symptom, and therefore not a direct answer to the question.

Concept Tested & Keywords

Concept Tested: Pathophysiology of menstrual dysfunction in Polycystic Ovary Syndrome (PCOS).
Stem keywords: Polycystic Ovary Syndrome, PCOS, menstrual symptoms
Lead-in keywords: correct about

Q8LlvtVJHuw0Z-MLmHezdB